These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11859909)

  • 1. Health outcomes evaluations: estimating the impact of almotriptan in managed care settings.
    Mayo KW; Osterhaus JT
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S85-93. PubMed ID: 11859909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Almotriptan versus sumatriptan in migraine treatment: direct medical costs of managing adverse chest symptoms.
    Mannix LK; Adelman JU; Goldfarb SD; Von S; Kozma CM
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S94-101. PubMed ID: 11859910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost savings in migraine associated with less chest pain on new triptan therapy.
    Wang JT; Barr CE; Torigoe Y; Wang E; Rowland CR; Goldfarb SD
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S102-7. PubMed ID: 11859905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistent efficacy, tolerability, and high levels of satisfaction with almotriptan 12.5 mg when used to treat multiple migraine attacks in routine clinical practice.
    Diener HC
    Headache; 2005 Jun; 45(6):624-31. PubMed ID: 15953293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic comparison of oral triptans for management of acute migraine: implications for managed care.
    Reeder CE; Steadman S; Goldfarb SD
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S80-4. PubMed ID: 11859908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Almotriptan: a review of pharmacology, clinical efficacy, and tolerability.
    Von S
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S74-9. PubMed ID: 11859907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
    Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
    Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management costs of chest and CNS-related adverse events associated with the treatment of acute migraine attacks with oral triptans].
    Slof J; Badia X; Lainez-Andres JM; Galvan J; Heras J
    Neurologia; 2005; 20(6):290-8. PubMed ID: 16007512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Headache; 2005; 45(7):874-82. PubMed ID: 15985104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical profile and practice experience of almotriptan.
    Gendolla A
    Cephalalgia; 2004; 24 Suppl 2():16-23. PubMed ID: 15595990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
    Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
    Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.
    Mullins CD; Subedi PR; Healey PJ; Sanchez RJ
    Pharmacotherapy; 2007 Aug; 27(8):1092-101. PubMed ID: 17655509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Almotriptan: meeting today's needs in acute migraine treatment.
    Láinez MJ
    Expert Rev Neurother; 2007 Dec; 7(12):1659-73. PubMed ID: 18052762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians.
    Lipton RB; Cutrer FM; Goadsby PJ; Ferrari MD; Dodick DW; McCrory D; Liberman JN; Williams P
    Curr Med Res Opin; 2005 Mar; 21(3):413-24. PubMed ID: 15811210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sumatriptan treatment for migraine in a health maintenance organization: economic, humanistic, and clinical outcomes.
    Cohen JA; Beall D; Beck A; Rawlings J; Miller DW; Clements B; Pait DG; Batenhorst A
    Clin Ther; 1999 Jan; 21(1):190-204. PubMed ID: 10090435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Almotriptan in the treatment of migraine attacks in clinical practice: results of the TEA 2000 observational study].
    Pascual J; Láinez JM; Leira R; Titus F; Mateos V; Galván J;
    Neurologia; 2003; 18(1):7-17. PubMed ID: 12590376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Almotriptan and zolmitriptan in the acute treatment of migraine.
    Goadsby PJ; Massiou H; Pascual J; Diener HC; Dahlöf CG; Mateos V; Dowson AJ; Raets I; Cunha L; Färkkilä M; Manzoni GC
    Acta Neurol Scand; 2007 Jan; 115(1):34-40. PubMed ID: 17156263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Almotriptan vs. ergotamine plus caffeine for acute migraine treatment. A cost-efficacy analysis].
    Slof J; Láinez JM; Comas A; Heras J
    Neurologia; 2009 Apr; 24(3):147-53. PubMed ID: 19418289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral almotriptan: practical uses in the acute treatment of migraine.
    Dowson AJ
    Expert Rev Neurother; 2004 May; 4(3):339-48. PubMed ID: 15853532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.